Cochlear | COH - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Ansell USD 1.97B 10.2M 2025-12
Avita Medical AUD -16.65M 3.76M 2025-12
Cochlear AUD 1.94B 12.2M 2025-12
CSL USD 18.66B 2.75B 2025-12
Fisher Paykel Healthcare NZD 2.12B 129.2M 2026-06
Healius AUD 1.03B 13.9M 2024-12
Integral Diagnostics AUD 301.71M 1.33M 2024-06
Mayne Pharma AUD 454.19M 93.58M 2024-06
Mesoblast USD 574.68M 22.76M 2025-12
Monash IVF AUD 253.91M 3.49M 2025-12
Nanosonics AUD 219.69M 9.78M 2025-12
Polynovo AUD 83.14M 121K 2025-12
Ramsay Health Care AUD 4.79B 916.1M 2025-12
Regis Healthcare AUD -29.95M 13.22M 2025-12
ResMed USD 6.49B 171.03M 2026-03
Sigma Healthcare AUD 4.67B 3.8B 2025-12
Somnomed AUD 22.4M 2.61M 2023-06
Sonic Healthcare AUD 8.2B 120.9M 2024-12
Telix Pharmaceuticals AUD 408.17M 8.69M 2026-06